Improvement of Sjögren's syndrome after two infusions of rituximab (anti-CD20)

MLA

Devauchelle-Pensec V, et al. “Improvement of Sjögren’s Syndrome after Two Infusions of Rituximab (Anti-CD20).” Arthritis & Rheumatism: Arthritis Care & Research, vol. 57, no. 2, Mar. 2007, pp. 310–17. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=106018289&authtype=sso&custid=ns315887.

APA

Devauchelle-Pensec V, Pennec Y, Morvan J, Pers J, Daridon C, Jousse-Joulin S, Roudaut A, Jamin C, Renaudineau Y, Roué IQ, Cochener B, Youinou P, & Saraux A. (2007). Improvement of Sjögren’s syndrome after two infusions of rituximab (anti-CD20). Arthritis & Rheumatism: Arthritis Care & Research, 57(2), 310–317.

Chicago

Devauchelle-Pensec V, Pennec Y, Morvan J, Pers J, Daridon C, Jousse-Joulin S, Roudaut A, et al. 2007. “Improvement of Sjögren’s Syndrome after Two Infusions of Rituximab (Anti-CD20).” Arthritis & Rheumatism: Arthritis Care & Research 57 (2): 310–17. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=106018289&authtype=sso&custid=ns315887.